2024 Lung Cancer Support Group Facilitator Awardee, Christine Conti
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
2d ago
Congratulations to our 2024 Lung Cancer Support Group Facilitator award recipient, Christine Conti, from Huntington Health in Pasadena, California. This award, given annually since 2009, recognizes the uncommon dedication of support group facilitators. Christine Conti, RN, ONN-CG, is a thoracic nurse navigator who has been Huntington Health’s lung cancer support group facilitator for 12 years. During the pandemic, Christine’s group grew when it went virtual, and in response to a growing demand for support during those uncertain times, Christine also increased the frequency of meetings. When ch ..read more
Visit website
“My Job is More Than a Job”
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
1w ago
Author: Meg Fay, BSN, RN, Nurse Manager, Excellence in Healthcare Delivery, GO2 for Lung Cancer My name is Meg, and I had the pleasure of experiencing the NYC Marathon 2024 as part of the GO2 Endurance Team. Coach Seth guided our team, offering multiple training programs that we could tailor to our individual needs and training webinars on everything from nutrition to injury prevention and beyond. We could follow along with our programs on the Final Surge app, which was fantastic and easy to use. We also had access to a private Facebook group, connecting us to others training ..read more
Visit website
2024 Lung Cancer Voices Summit Recap
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
1w ago
GO2 for Lung Cancer’s Voices Summit is the only annual meeting that brings the lung cancer community together for education, training, connection, and advocacy action with our federal government, the largest funder of cancer research.   This month, nearly 200 advocates from 31 states gathered in Washington, D.C., for the 2024 Voices Summit. Attendees learned about the latest in lung cancer treatment and research, received advocacy training, connected with fellow attendees from across the country, and took on Capitol Hill to share their unique stories with their representatives to deman ..read more
Visit website
How One Survivor Became an Advocate: Perspectives from a Voices Summit First-Timer
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
1w ago
Earlier this month, Oakland-based photographer Genevieve joined nearly 200 other lung cancer advocates in Washington, D.C., to share her story with Congressional members and urge support for lung cancer research. We talked to her about her experience as one of 109 first-time participants at the GO2 for Lung Cancer Voices Summit in 2024. How did you become interested in attending the Voices Summit? I hadn’t met any lung cancer survivors until I got involved with GO2. In the beginning, after I received my diagnosis of stage 3 (III) lung cancer, I was so overwhelmed. Only later, after I recove ..read more
Visit website
Living Room Show Notes: Women and Lung Cancer 
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
2w ago
Women living with or at risk for lung cancer often have different, and sometimes worse, experiences than men with the same disease. This is due in part to biological differences between men and women and in part to the historical exclusion of women in clinical trials. This has resulted in drugs that were tested predominantly on men and may affect women in different ways.  Women, on average, are also diagnosed with lung cancer at younger ages than men and with shorter smoking histories, calling into question whether the United States Preventative Services Task Force’s (USPSTF) screening g ..read more
Visit website
Ask the Experts: What Does it Mean to Develop Resistance to Treatment?
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
2w ago
Question: I was recently diagnosed with lung cancer and am on my first line of treatment. I keep hearing that at some point I may develop a resistance to that treatment. What exactly does that mean and how long might I have before resistance develops?   (Answered by Dr. Jyoti Malhorta by City of Hope Comprehensive Cancer Center during her appearance on the Lung Cancer Living Room. It has been edited slightly for this use.)  Answer: When a patient is on a cancer treatment, many times it works for a certain period of time but for advanced lung cancer, we know that the treatment d ..read more
Visit website
Mary’s Lung Cancer Story: It Doesn’t Stop You From Living
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
2w ago
For people diagnosed with lung cancer, receiving a second opinion can be an important step in confirming treatment decisions or opting for a new approach to treatment.   In Mary Burlie’s case, getting a second opinion changed everything. Although her first oncologist did not believe that Mary’s lung cancer had a treatable biomarker, a second opinion from Dr. Jonathon Riess at UC Davis showed that she was eligible for targeted therapy, a pill she now takes just once a day.   “The treatments now are so good and so advanced, that it doesn’t stop you from living. So, I’m livi ..read more
Visit website
FDA Approves Rybrevant (amivantamab-vmjw) for Non-small Cell Lung Cancer with EGFR-Exon 20 Mutation
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
3w ago
On March 1, 2024, the U.S. Food and Drug Administration (FDA) approved the drug Rybrevant (amivantamab-vmjw) to be given in combination with carboplatin and pemetrexed in the first lining setting for people with metastatic non-small cell lung cancer (NSCLC) with an EGFR exon 20 mutation. They also announced traditional approval for Rybrevant (amivantamab-vmjw) to be given to people with metastatic non-small cell lung cancer (NSCLC) who are positive for an EGFR exon 20 mutation after they have experienced progression or recurrence while on or after platinum-based chemotherapy. This decision is ..read more
Visit website
Meet HealthUnlocked’s “Denzie:” Celebrating 13 Years of Survival
GO2 Foundation for Lung Cancer
by Sarah Wilson
1M ago
If you have spent any time in GO2’s online support community, HealthUnlocked, you have likely come across posts, advice or support from a member who calls herself “Denzie.” Denzie volunteers as a dedicated moderator, welcomes new users, answers questions and provides encouragement and comradery to others who are also living with lung cancer. Denzie is the username of Denise Cutlip, a stage 4 (IV) lung cancer patient who celebrated an incredible 13 years of survival at the end of 2023. Since her diagnosis, Denise has dedicated herself to learning and sharing as much as she can abou ..read more
Visit website
Ask the Experts: What’s New in SCLC Research?  
GO2 Foundation for Lung Cancer
by Bethany Johnson (GO2 for Lung Cancer)
1M ago
Question: I have small cell lung cancer (SCLC). What’s new in research related to SCLC? What should I know about clinical trials?  (Answered by Dr. Jacob Sands from Dana-Farber Cancer Institute during his appearance on the Lung Cancer Living Room. It has been edited slightly for this use.)   Answer: There is a lot of research being done on SCLC with a strong focus on finding new and better treatments.   DLL3-targeted drugs  The most novel therapies right now are those that target DLL3. DLL3 is a receptor on the surface of many small cell lung cancers. The study t ..read more
Visit website

Follow GO2 Foundation for Lung Cancer on FeedSpot

Continue with Google
Continue with Apple
OR